Publications by authors named "Daniel Meibom"

Claim this Profile
L
Linker-Determined Folding and Hydrophobic Interactions Explain a Major Difference in PROTAC Cell Permeability.
Vasanthanathan Poongavanam, Stefan Peintner, Yordanos Abeje, Florian Kölling, Daniel Meibom

ACS Med Chem Lett· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Linker Composition on VHL PROTAC Cell Permeability.
Yordanos Esubalew Abeje, Lianne H E Wieske, Vasanthanathan Poongavanam, Stefanie Maassen, Yoseph Atilaw, Daniel Meibom

J Med Chem· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BAY-9835: Discovery of the First Orally Bioavailable ADAMTS7 Inhibitor.
Daniel Meibom, Pierre Wasnaire, Kristin Beyer, Andreas Broehl, Yolanda Cancho-Grande

J Med Chem· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and Preclinical Characterization Program toward Asundexian (BAY 2433334), an Oral Factor XIa Inhibitor for the Prevention and Treatment of Thromboembolic Disorders.
Susanne Roehrig, Jens Ackerstaff, Eloísa Jiménez Núñez, Henrik Teller, Pascal Ellerbrock, Daniel Meibom

J Med Chem· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BAY-6096: A Potent, Selective, and Highly Water-Soluble Adrenergic α Antagonist.
Daniel Meibom, Jutta Meyer, Clemens-Jeremias von Buehler, Karl D Collins, Stefanie Maassen

J Med Chem· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive Modeling of PROTAC Cell Permeability with Machine Learning.
Vasanthanathan Poongavanam, Florian Kölling, Anja Giese, Andreas H Göller, Lutz Lehmann, Daniel Meibom

ACS Omega· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BAY-7081: A Potent, Selective, and Orally Bioavailable Cyanopyridone-Based PDE9A Inhibitor.
Daniel Meibom, Sina Micus, Anna Lena Andreevski, Sonja Anlauf, Pamela Bogner

J Med Chem· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Linker-Dependent Folding Rationalizes PROTAC Cell Permeability.
Vasanthanathan Poongavanam, Yoseph Atilaw, Stephan Siegel, Anja Giese, Lutz Lehmann, Daniel Meibom

J Med Chem· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Solution Conformations Shed Light on PROTAC Cell Permeability.
Yoseph Atilaw, Vasanthanathan Poongavanam, Caroline Svensson Nilsson, Duy Nguyen, Anja Giese, Daniel Meibom

ACS Med Chem Lett· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potent and Selective Human Prostaglandin F (FP) Receptor Antagonist (BAY-6672) for the Treatment of Idiopathic Pulmonary Fibrosis (IPF).
Hartmut Beck, Tobias Thaler, Daniel Meibom, Mark Meininghaus, Hannah Jörißen

J Med Chem· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel non-xanthine antagonist of the A adenosine receptor: From HTS hit to lead structure.
Michael Härter, Bernd Kalthof, Martina Delbeck, Klemens Lustig, Michael Gerisch, Daniel Meibom

Eur J Med Chem· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neladenoson Bialanate Hydrochloride: A Prodrug of a Partial Adenosine A Receptor Agonist for the Chronic Treatment of Heart Diseases.
Daniel Meibom, Barbara Albrecht-Küpper, Nicole Diedrichs, Walter Hübsch, Raimund Kast

ChemMedChem· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potent and Selective Human Neutrophil Elastase Inhibitors with Novel Equatorial Ring Topology: in vivo Efficacy of the Polar Pyrimidopyridazine BAY-8040 in a Pulmonary Arterial Hypertension Rat Model.
Franz von Nussbaum, Volkhart M Li, Daniel Meibom, Sonja Anlauf, Martin Bechem

ChemMedChem· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Freezing the Bioactive Conformation to Boost Potency: The Identification of BAY 85-8501, a Selective and Potent Inhibitor of Human Neutrophil Elastase for Pulmonary Diseases.
Franz von Nussbaum, Volkhart M-J Li, Swen Allerheiligen, Sonja Anlauf, Lars Bärfacker, Daniel Meibom

ChemMedChem· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis